NA
Navas Abdul Rehuman
About Navas Abdul Rehuman
Data last updated:
Navas Abdul Rehuman is a Director at Naajco Contracting Private Limited (since 2022) and Director at Citwal Pharmaceuticals Private Limited (since 2018). The companies operate in Machinery and Equipment and Business Services.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Naajco Contracting Private Limited U45100KL2017PTC051061 | Director | 25 Oct 2022 | 2017 | Active | |
| Citwal Pharmaceuticals Private Limited U74999KL2018PTC052557 | Director | 21 Mar 2018 | 2018 | Active |
Board colleagues of Navas Abdul Rehuman
| Name | DIN | Company | Designation |
|---|---|---|---|
| Lenin Madhava Kurup | 03149789 | Naajco Contracting Private Limited | Director |
| Shaji Subair Sahib | 07132257 | Naajco Contracting Private Limited | Director |
| Pradeep Kumar Muraleedharannair | 08091743 | Citwal Pharmaceuticals Private Limited | Director |
| Vasumathi Nadarajan Rijees | 07480073 | Citwal Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navas Abdul Rehuman
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navas Abdul Rehuman
Navas Abdul Rehuman currently holds 2 directorships: Naajco Contracting Private Limited (Director, since 25 Oct 2022); Citwal Pharmaceuticals Private Limited (Director, since 21 Mar 2018).
Navas Abdul Rehuman was first appointed on 21 Mar 2018 as Director at Citwal Pharmaceuticals Private Limited. The most recent appointment on record is 25 Oct 2022 at Naajco Contracting Private Limited.
The current boards of Navas Abdul Rehuman's companies include Lenin Madhava Kurup (Naajco Contracting Private Limited), Shaji Subair Sahib (Naajco Contracting Private Limited), Pradeep Kumar Muraleedharannair (Citwal Pharmaceuticals Private Limited), Vasumathi Nadarajan Rijees (Citwal Pharmaceuticals Private Limited).